Saddle River, New Jersey, United States The company was established in North America in United States. The leading representative office of defined VC is situated in the Saddle River.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018. The important activity for fund was in 2015. The real fund results show that this VC is 8 percentage points less often commits exit comparing to other companies. Comparing to the other companies, this Sabby Management performs on 57 percentage points more the average number of lead investments.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Therapeutics, Hospital. Among the most popular portfolio startups of the fund, we may highlight Epic Sciences, Medigus, Outlook Therapeutics.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Sabby Management, startups are often financed by RMI Partners, Pfizer Venture Investments, Domain Associates. The meaningful sponsors for the fund in investment in the same round are Wellington Management, RA Capital Management, Perceptive Advisors. In the next rounds fund is usually obtained by Wild Basin Investments, Merieux Developpement, Square 1 Bank.
The overall number of key employees were 1.
Related Funds
Funds with similar focus
| Fund Name | Location |
| American Tire Distributors | Huntersville, North Carolina, United States |
| Beijing Zhongshang Huatong Electronics | Beijing, Beijing, China |
| Beijing Zunhao Investment | Beijing, Beijing, China |
| Coppel Family | - |
| DGNL Ventures | New York, New York, United States |
| Firstrock Capital | New York, New York, United States |
| Huake Caifu Touzi | Beijing, China, Haidian |
| I-O Data Device | Ishikawa Prefecture, Japan, Kanazawa |
| Koonras Technologies | Israel, Tel Aviv, Tel Aviv District |
| Marathon Venture Partners | China, Shanghai |
| Niche Capital | Lagos, Lagos, Nigeria |
| Nippon Life Insurance Company of Japan | Japan, Osaka, Osaka Prefecture |
| Nordic Development Fund | - |
| Renaissance KMU Schweizerische Anlagestiftung | Lausanne, Switzerland, Vaud |
| Rockport Venture Partners | New Jersey, Spring Lake, United States |
| Sanjo Shinkin Bank | - |
| Shenzhen Linhong Ruifeng Touzi Guanli Youxian Zeren Gongsi | China, Guangdong, Tianjin |
| Topsailing Capital | China, Guangdong, Shenzhen |
| Xian Haichuang Zhixing Chuangye Touzi | China, Shaanxi, Xian Shi |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Xeris Pharmaceuticals | $41M | 07 Jan 2016 | Chicago, Illinois, United States | ||
UNUM Therapeutics | $65M | 11 Jun 2015 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Xeris Pharmaceuticals | $41M | 07 Jan 2016 | Chicago, Illinois, United States | ||
UNUM Therapeutics | $65M | 11 Jun 2015 | Cambridge, Massachusetts, United States |
